Table 3.
Follow up (n=77)
| MBM (n=38) | ER-cap (n=39) | p-value | |
|---|---|---|---|
|
| |||
| Median follow up | 15 months (IQR 13–17) | 15 months (IQR 12–21) | 0.54 |
|
| |||
| Median number of follow up visits | 2 (IQR 2–3) | 2 (IQR 2–3) | 0.78 |
|
| |||
| Worst histology of scar at 3 month follow up: | 0.44 | ||
| normal squamous | 32 | 30 | |
| LGIN | 6 | 8 | |
| MGIN | 0 | 1 | |
| Worst histology of scar at last follow up: | 0.63 | ||
| normal squamous | 31 | 34 | |
| LGIN | 7 | 5 | |
|
| |||
| Worst histology of USLs >1cm from scar at 3 month follow up | (n=26) | (n=29) | 0.39 |
| normal squamous | 21 | 18 | |
| LGIN | 3 | 9 | |
| MGIN | 1 | 2 | |
| HGIN | 1 | 0 | |
| Worst histology of (USL) >1cm from scar at last follow up: | 0.61 | ||
| normal squamous | 33 | 35 | |
| LGIN | 5 | 4 | |
NS: not significant; IQR: interquartile range; LGIN: low grade intraepithelial neoplasia; MGIN: moderate grade intraepithelial neoplasia; HGIN: high grade intraepithelial neoplasia; ESCC: esophageal squamous cell carcinoma